FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention is aimed at compound in accordance with formula (R2R3)-B1-A1-c(A2-A3-A4-A5-A6-A7-A8-A9)-A10-A11-A12-A13-B2-B3-R1, which act as ligands for one or several melanocortin receptors, their pharmaceutically acceptable salts.
EFFECT: elaboration of method of peptide application and obtaining pharmaceutical compositions, which include said peptides.
132 cl, 4 tbl, 4 ex
Title |
Year |
Author |
Number |
APPLICATION OF MELANOCORTIN FOR TREATING INSULIN SENSITIVITY |
2008 |
- Khejlem Khehzer A.
- Kaller Majkl Devitt
- Batler Ehndrju A.
|
RU2453328C2 |
METHOD FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCORTIN 4 RECEPTOR PATH |
2016 |
- Ploeg, Leonardus, H.T. Van Der
- Henderson, Bart
- Kuhnen, Peter
|
RU2785889C1 |
MELANOCORTIN RECEPTOR LIGANDS |
2006 |
- Dong Chzhen Ksin
- Moro Zhak-P'Er
|
RU2439079C2 |
MELANOCORTIN RECEPTOR LIGANDS |
2006 |
- Dong Chzhen Ksin
- Moro Zhak-P'Er
|
RU2380372C2 |
ALPHA- AND GAMMA-MSH ANALOGUES |
2013 |
|
RU2668791C2 |
PEPTIDIC INTERLEUKIN-23 RECEPTOR INHIBITORS FOR ORAL ADMINISTRATION AND USE THEREOF FOR TREATING INFLAMMATORY INTESTINAL DISEASES |
2015 |
- Bourne, Gregory
- Bhandari, Ashok
- Cheng, Xiaoli
- Frederick, Brian Troy
- Zhang, Jie
- Patel, Dinesh V.
- Liu, David
|
RU2736637C2 |
PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS |
2010 |
- Yuj Chunsi
- Syuj Lina
- Chen Yujkhua
- Yan Binbin
- Tu Shitsyan
|
RU2627065C2 |
KV1_3 BLOCKERS |
2020 |
- Munch, Henrik Fischer
- Jensen, Rasmus Bugge
- Madsen, Jens Kvist
|
RU2825633C1 |
PEPTIDE VECTORS |
2004 |
- Dong Chzhen Ksin
- Shen Jilana
- Komstok Dzhinn Mehri
- Kim San Kh.
|
RU2361876C2 |
MUTANT NITRILE HYDRATASE, NUCLEIC ACID WHICH ENCODES SAID MUTANT NITRILE HYDRATASE, EXPRESSION VECTOR AND TRANSFORMANT CONTAINING SAID NUCLEIC ACID, METHOD OF PRODUCING SAID MUTANT NITRILE HYDRATASE AND METHOD OF PRODUCING AMIDE COMPOUND |
2017 |
- Tateno Toshihiro
- Tokuda Junko
- Kai Keiichirou
|
RU2736086C1 |